Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=28275444
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
The impact of Thailand s public health response to the HIV epidemic 1984-2015:
understanding the ingredients of success
#MMPMID28275444
Siraprapasiri T
; Ongwangdee S
; Benjarattanaporn P
; Peerapatanapokin W
; Sharma M
J Virus Erad
2016[Nov]; 2
(Suppl 4
): 7-14
PMID28275444
show ga
INTRODUCTION: Thailand has been heralded as a global leader in HIV prevention and
treatment, and its experience with the HIV/AIDS epidemic holds valuable lessons
for public health. This paper documents Thailand's response to its HIV epidemic
from the late 1980s until today, and analyses its epidemiological impact
(incidence and mortality). We discuss the association between the trajectory of
HIV incidence and mortality rates over time, and the programmatic investments,
policies and interventions that were implemented in the last three decades.
METHODS: This is a review paper that draws on published literature, unpublished
sources and routine behavioural and serological surveillance data since 1989. It
is informed by the modelling of epidemiological impacts using the AIDS Epidemic
Model. The AIDS Epidemic Model and Spectrum were used to assess the impact on
incidence and mortality. Apart from epidemiological data, National AIDS Spending
Assessment and programme data were also used to assess financial investments.
RESULTS: Thailand is well on its way to meeting the 90-90-90 targets, the goal
that by 2020, 90% of people living with HIV know their HIV status, 90% of people
with diagnosed HIV infection receive sustained antiretroviral therapy, and 90% of
people receiving antiretroviral therapy (ART) are virally suppressed. In
Thailand, 89% of people living with HIV know their status, 72% receive ART and
82% have viral load testing - 99% of whom are suppressed. The public health
response to HIV in Thailand has averted 5.7 million infections since 1991. If
Thailand had not responded in 1991 to the HIV epidemic, and had there been no
prevention and ART provision, the country would have experienced an estimated
158,000-225,000 deaths in the 2001-2006 period. This figure would have risen to
231,000-268,924 in the 2007-2014 period. A total of 196,000 deaths were averted
between 2001 and 2014. If ART scale-up had not occurred in 2001, Thailand would
have experienced between 50,000 and 55,000 deaths per year in the period
2001-2006, and 31,000-46,000 annual deaths between 2007 and 2014. The main impact
in terms of deaths averted is seen from 2004 onwards, reflecting treatment scale
up. CONCLUSIONS: Thailand's AIDS response has prevented needless morbidity and
mortality due to the HIV epidemic. In the context of Thailand's ageing
population, it is faced with the twin challenges of maintaining life-long quality
services among HIV patients and sustaining behaviour change to maintain primary
prevention gains. Keeping the focus of the policy makers and health
administrators on 'Ending the HIV epidemic' will require consistent advocacy, and
evidence-based, innovative and efficient approaches.